4.4 Article

2013 American College of Rheumatology/European League Against Rheumatism Classification Criteria for Systemic Sclerosis Outperform the 1980 Criteria: Data From the Canadian Scleroderma Research Group

期刊

ARTHRITIS CARE & RESEARCH
卷 67, 期 4, 页码 582-587

出版社

WILEY
DOI: 10.1002/acr.22451

关键词

-

资金

  1. Canadian Institutes of Health Research [FRN83518]
  2. Scleroderma Society of Canada
  3. Scleroderma Society of Ontario, Sclerodermie Quebec
  4. Cure Scleroderma Foundation
  5. Inova Diagnostics
  6. Dr. Fooke Laboratorien
  7. Euroimmun
  8. Mikrogen
  9. Fonds de Recherche du Quebec-Sante
  10. Canadian Arthritis Network
  11. Lady Davis Institute of Medical Research of the Jewish General Hospital, Montreal
  12. Pfizer
  13. Actelion
  14. AbbVie
  15. Roche
  16. Janssen
  17. BMS
  18. Celgene
  19. Genentech
  20. Amgen
  21. Eli Lilly
  22. GlaxoSmithKline
  23. Johnson and Johnson
  24. Bristol-Myers Squibb

向作者/读者索取更多资源

ObjectiveThe goal of this study was to determine the sensitivity of the new 2013 classification criteria for systemic sclerosis (SSc; scleroderma) in an independent cohort of SSc subjects and to assess the contribution of individual items of the criteria to the overall sensitivity. MethodsSSc subjects from the Canadian Scleroderma Research Group cohort were assessed. Sensitivity was determined in several subgroups of patients. In patients without the criterion of skin thickening proximal to the metacarpophalangeal (MCP) joints, we recalculated sensitivity after removing the individual criterion. ResultsA total of 724 SSc patients were included. Most were women (86%), mean age was 55.8 years, mean disease duration was 10.9 years, and 59% had limited cutaneous SSc (lcSSc). Overall, the sensitivity of the 2013 criteria was 98.3% compared to 88.3% for the 1980 criteria. This pattern was consistent among those with lcSSc (98.8% versus 85.6%), anticentromere antibodies (98.9% versus 79.8%), disease duration 3 years (98.7% versus 84.7%), and no skin involvement proximal to the MCP joints (97% versus 60%). In the latter subgroup, removing Raynaud's phenomenon and sclerodactyly from the criteria reduced the sensitivity to 77% and 79%, respectively. Removing both sclerodactyly and puffy fingers reduced the sensitivity to 62%. ConclusionThe 2013 SSc classification criteria classify more SSc patients than the 1980 criteria. The improvement in sensitivity is most striking in those with lcSSc, especially those without skin involvement proximal to the MCP joints. The addition of Raynaud's phenomenon and puffy fingers to the 2013 criteria accounts for important gains in sensitivity.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.4
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据